NCT05625945View on ClinicalTrials.gov

Physical Activity Levels and Statin Therapy

CompletedOBSERVATIONAL
Enrollment

196

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

November 16, 2023

Study Completion Date

November 16, 2023

Conditions
Cardiovascular DiseasesHMG COA Reductase Inhibitor Adverse ReactionMuscle Pain
Interventions
BEHAVIORAL

Physical activity monitoring

Physical activity patterns will be measured using the activPAL3 micro monitor

Trial Locations (1)

6525 EX

Department of Physiology, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT05625945 - Physical Activity Levels and Statin Therapy | Biotech Hunter | Biotech Hunter